Effects of cognitive behavioral therapy for patients with rheumatoid arthritis: a systematic review and meta-analysis
العنوان: | Effects of cognitive behavioral therapy for patients with rheumatoid arthritis: a systematic review and meta-analysis |
---|---|
المؤلفون: | Huiling Li, Biyu Shen, Yu-Cheng Xu, Xian Du, Guang-Yin Xu, Yong-Chang Li, Haoyang Chen |
المصدر: | Psychology, Health & Medicine. 25:1179-1191 |
بيانات النشر: | Informa UK Limited, 2020. |
سنة النشر: | 2020 |
مصطلحات موضوعية: | medicine.medical_specialty, medicine.medical_treatment, Anxiety, Cochrane Library, law.invention, Arthritis, Rheumatoid, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Internal medicine, medicine, Humans, 030212 general & internal medicine, Fatigue, Applied Psychology, Depression (differential diagnoses), Cognitive Behavioral Therapy, business.industry, medicine.disease, Confidence interval, 030227 psychiatry, Cognitive behavioral therapy, Psychiatry and Mental health, Clinical Psychology, Meta-analysis, Rheumatoid arthritis, medicine.symptom, business |
الوصف: | This study aimed to assess the effects of cognitive behavioral therapy on the psychological and physiological health of rheumatoid arthritis patients. An extensive literature search was conducted, using the PubMed, Web of Science, Cochrane Library, Embase, CNKI Scholar, WanFang, and VIP databases, from inception to December2018. The quality of the studies was evaluated by 2 independent authors, according to the basic criteria provided by the Cochrane Handbook for evaluating randomized trials. Meta-analysis was performed with Review Manager 5.3. Six randomized controlled trials met the inclusion criteria of the current study. Using standard mean differences (SMD) and 95% confidence intervals (CI), our results showed that cognitive behavioral therapy could significantly reduce levels of anxiety (SMD = -0.30, 95% CI [-0.52, -0.09], P= 0.005) and depression (SMD = -0.48, 95% CI [-0.70, -0.27], P< 0.00001), and relieve fatigue symptoms (SMD = -0.35, 95% CI [-0.60, -0.10], P= 0.006) in rheumatoid arthritis patients.This is the first known assessment of the efficacy of cognitive behavioral therapy on rheumatoid arthritis patients using meta-analysis. Large-scale randomized controlled trials need to be implemented to further explore this issue. |
تدمد: | 1465-3966 1354-8506 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c53be05fe5d66f3c559ac55191f3da9 https://doi.org/10.1080/13548506.2020.1736312 |
رقم الأكسشن: | edsair.doi.dedup.....8c53be05fe5d66f3c559ac55191f3da9 |
قاعدة البيانات: | OpenAIRE |
تدمد: | 14653966 13548506 |
---|